PANACEA BIOTEC
Back to Income Statement
|
PANACEA BIOTEC Last 5 Year Revenue History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Net Sales | ₹559 Cr | ₹559 Cr | ₹460 Cr | ₹661 Cr | ₹625 Cr |
What is the latest Revenue of PANACEA BIOTEC ?
| Year | Revenue |
|---|---|
| Mar2025 | ₹559 Cr |
| Mar2024 | ₹559 Cr |
| Mar2023 | ₹460 Cr |
| Mar2022 | ₹661 Cr |
| Mar2021 | ₹625 Cr |
How is Revenue of PANACEA BIOTEC Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2025 | ₹559 Cr | -0.01 | |
| Mar2024 | ₹559 Cr | 21.57 | |
| Mar2023 | ₹460 Cr | -30.44 | |
| Mar2022 | ₹661 Cr | 5.83 | |
| Mar2021 | ₹625 Cr | - | |
Compare Revenue of peers of PANACEA BIOTEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PANACEA BIOTEC | ₹3,729.8 Cr | 40.3% | 56.8% | 15.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹426,938.0 Cr | -0.6% | -3.7% | 7.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,361.0 Cr | 2.8% | 0.7% | -0.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹151,385.0 Cr | 2.4% | 2.1% | 40.8% | Stock Analytics | |
| CIPLA | ₹111,220.0 Cr | 0.1% | 2.2% | -5.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,899.0 Cr | 0.5% | -1.9% | 2.2% | Stock Analytics | |
PANACEA BIOTEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PANACEA BIOTEC | 40.3% |
56.8% |
15.5% |
| SENSEX | -1% |
-5% |
-9.2% |
You may also like the below Video Courses